PP_1170x120_10-25-21

generic version of Imitrex

Lannett set to launch generic of Imitrex nasal spray

Lannett set to launch generic of Imitrex nasal spray

PHILADELPHIA — Lannett Co. has received approval from the Food and Drug Administration for sumatriptan nasal spray (5 mg/spray and 20 mg/spray), a treatment for migraine headaches. Lannett said its product is a generic version of Imitrex nasal spray from GlaxoSmithKline. “We believe our sumatriptan nasal spray (USP, 5 mg/spray and 20 mg/spray) will be